NUF2 and non-small cell lung carcinoma: 1,144 patients with NSCLC divided into two groups according to the median transcription levels of NUF2, and we also analyzed the prognosis of LUAD (672 patients) and LUSC (271 patients) based on the median of NUF2 expression by Kaplan-Meier plotter.